Figure 5.
Proposed mechanism. Through inhibition of the NFκB p65 subunit, linagliptin can down-regulate IL-1β and ICAM-1 expression. By increasing eNOS expression, linagliptin can ameliorate tissue factor activity.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.